Plain-English translation of NCT05848557 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing mSaada, a mobile health app designed to make cervical cancer screening easier and more accessible for women in western Kenya. The app helps community health workers provide screening counseling, track patient information, and manage follow-up care. Researchers want to see if using this app helps more women get screened and improves their knowledge about cervical cancer and HPV.
Many women in remote or rural areas of Kenya don't have access to cervical cancer screening because healthcare infrastructure is limited. This trial exists to see whether a mobile app can help community health workers bring screening directly to women's homes and make the whole process more efficient and effective.
You likely qualify if…
You likely don't qualify if…
If you are a woman participant, you may be offered home-based HPV screening by a community health worker who uses either the mSaada app or standard paper-based methods. You will also be asked to complete a brief survey about your knowledge of cervical cancer and HPV, and your feelings about screening. The study runs for 18 months across multiple health facilities in the region.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Kenya
Collaborators
National Cancer Institute (NCI)
Enrollment target
~6,000 participants
Started
February 2024
Primary completion
June 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Megan Huchko, MD, MPH
Duke University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.